Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000405613 | SCV000335063 | likely benign | not specified | 2016-09-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000405613 | SCV000615581 | uncertain significance | not specified | 2016-12-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000528735 | SCV000649067 | likely benign | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200484 | SCV001371457 | uncertain significance | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001200484 | SCV001813355 | likely benign | not provided | 2019-03-27 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28017257) |
Baylor Genetics | RCV003147439 | SCV003835064 | uncertain significance | Autosomal recessive ataxia, Beauce type | 2021-06-29 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001200484 | SCV001806827 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001200484 | SCV001964202 | uncertain significance | not provided | no assertion criteria provided | clinical testing |